AstraZeneca, Ranbaxy prevail in Nexium antitrust trial
December 05, 2014 at 15:41 PM EST
Dec 5 (Reuters) - A Massachusetts jury has found that an agreement between AstraZeneca Plc and Ranbaxy Laboratories Ltd to delay the launch of a generic version of AstraZeneca's heartburn drug Nexium was not anticompetitive.
